`biyoteknoloji` ile İlgili Madde Sonuçları

Biorefinery facilities are integrated production centers where energy, fuel, chemicals, and high value-added products are obtained from biomass through sustainable methods. In these facilities, renewable biological resources are utilized as an alternative to fossil fuel use, and efforts are made to minimize environmental impacts. In recent years, especially microalgae-based biorefinery systems have become a significant area of research and application in terms of biofuel production and the reduc

Owkin is an artificial intelligence–driven biotechnology company focused on deciphering biological knowledge and optimizing medical decision-making. The company’s mission is to understand disease biology at multiple scales, guide target selection, support clinical development, and enhance diagnostic decision processes. To achieve this, Owkin is developing a framework it calls Biological Artificial Superintelligence (BASI)—a closed-loop system that integrates agentic AI architectures, multimodal

Isomorphic Labs is a commercial enterprise founded in 2021 under Alphabet, created to rethink drug discovery from first principles through an AI-first approach. The company operates on the premise that an isomorphic structure exists between biology and information science, using digital biology methods to model, design, and evaluate biological systems at the molecular level. Its long-term goal is to accelerate AI-driven drug design to develop effective therapies for serious diseases and, ultimat

Arzeda is a synthetic biology company focused on protein and enzyme design. The company combines physics-based computational protein design and artificial intelligence methods with DNA synthesis and automation-supported laboratory validation processes to provide its partners with custom functional protein and enzyme solutions across sectors such as food, personal care, material technologies, and biopharmaceuticals. Headquartered in Seattle, Washington, Arzeda operates with the goal of commercial

Valo Health is a technology-driven biopharmaceutical company dedicated to transforming the drug discovery and development process through AI-powered integration of large-scale human data. The company’s mission is to unify every stage of drug development — from target identification to clinical design — within a single, intelligent computational architecture. This approach aims to reduce the cost, duration, and failure rate of drug development while accelerating the delivery of new treatments to

Insitro is a biotechnology company that integrates machine learning and high-throughput biology to redefine the process of drug discovery and development through data-driven science. Founded in 2018 by computer scientist Daphne Koller, the company is headquartered in South San Francisco, California. Insitro’s mission is to accelerate the development of more effective and accessible medicines by decoding the complexity of human diseases through the measurement and modeling of biological data. Mis

Deep Genomics is a biotechnology company specializing in artificial intelligence–driven genetic therapy development. Headquartered in Toronto, Ontario, Canada, with an additional office in Boston, Massachusetts, the company operates on the principle that the future of medical innovation lies in artificial intelligence, given the inherent complexity of biological systems. Deep Genomics develops AI-based biological models to identify and treat genetic disorders. Scientific Approach and Research Fo

Healx is a technology-driven biotechnology company that combines artificial intelligence and drug development expertise to accelerate the discovery of new treatments for rare diseases. Founded in 2014 by Dr. Tim Guilliams and Dr. David Brown in Cambridge, United Kingdom, Healx aims to address the global challenge that only about 5% of nearly 10,000 known rare diseases currently have an approved therapy. The company adopts a patient-inspired approach, focusing on overcoming barriers faced by rare

The 9th National Antarctic Scientific Expedition (TAE-IX) is a scientific research mission conducted under the auspices of the Presidency of Türkiye, overseen by the Ministry of Industry and Technology, and coordinated by the Polar Research Institute of TÜBİTAK Marmara Research Center (MAM). The expedition aims to continue Türkiye's scientific studies in Antarctica. It began on February 6, 2025, and is scheduled to conclude on March 12, 2025. Objective and Scope The primary goal of the expeditio

Nanotechnology is a field of science that involves designing, manufacturing, and applying materials and devices at the atomic and molecular levels. It is based on manipulating matter at the nanometer scale (1-100 nm). This technology intersects various disciplines such as material science, physics, chemistry, biology, and engineering. Nanotechnology has led to revolutionary advancements in electronics, medicine, energy, and environmental sciences. History of Nanotechnology The conceptual foundat